Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ZOGENIX, INC. | 169,251 | reported | 16 Sept 2011 | tx 8+169,251−71,145 |
| TANDEM DIABETES CARE INC | 54,390 | reported | 19 Nov 2013 | tx 6+60,398−64,458 |
| Orexigen Therapeutics, Inc. | 50,643 | reported | 22 Dec 2011 | tx 18+54,352 |
| OBALON THERAPEUTICS INC | 49,570 | reported | 12 Oct 2016 | tx 4+49,570−45,937 |
| Neothetics, Inc. | 46,923 | reported | 25 Nov 2014 | tx 11+50,708−263,100 |
| Evoke Pharma Inc | 10,328 | reported | 26 May 2016 | tx 3+19,006−24,886 |
| Clovis Oncology, Inc. | 0 | reported | 21 Nov 2011 | tx 9+51,013−84,289 |
| Regado Biosciences Inc | 0 | reported | 01 Nov 2016 | tx 1−47,613 |
| Achaogen Inc | 0 | reported | 17 Mar 2014 | tx 4+33,890−33,890 |
| Esperion Therapeutics, Inc. | 0 | reported | 01 Jul 2013 | tx 5+36,446−38,808 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Nov 2016 | TENDER | Regado Biosciences Inc | 47,613 | 28.35 USD | |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 49,570 | — | |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 11,083 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 14,271 | 0.00 USD | deriv |
| 12 Oct 2016 | CONVERSION | OBALON THERAPEUTICS INC | 20,583 | 0.00 USD | deriv |
| 26 May 2016 | SALE | Evoke Pharma Inc | 5,880 | 4.70 USD | |
| 19 Mar 2014 | OTHER | CADENCE PHARMACEUTICALS INC | 50,743 | 14.00 USD | |
| 17 Mar 2014 | CONVERSION | Achaogen Inc | 33,890 | — | |
| 17 Mar 2014 | CONVERSION | Achaogen Inc | 7,430 | 0.00 USD | deriv |
| 17 Mar 2014 | CONVERSION | Achaogen Inc | 15,799 | 0.00 USD | deriv |
| 17 Mar 2014 | CONVERSION | Achaogen Inc | 10,661 | 0.00 USD | deriv |
| 19 Nov 2013 | CONVERSION | TANDEM DIABETES CARE INC | 54,390 | — | |
| 19 Nov 2013 | CONVERSION | TANDEM DIABETES CARE INC | 6,071 | 0.00 USD | deriv |
| 19 Nov 2013 | CONVERSION | TANDEM DIABETES CARE INC | 9,378 | 0.00 USD | deriv |
| 19 Nov 2013 | OTHER | TANDEM DIABETES CARE INC | 6,008 | 0.00 USD | deriv |
| 19 Nov 2013 | OTHER | TANDEM DIABETES CARE INC | 10,068 | 0.00 USD | deriv |
| 19 Nov 2013 | CONVERSION | TANDEM DIABETES CARE INC | 38,941 | 0.00 USD | deriv |
| 30 Sept 2013 | CONVERSION | Evoke Pharma Inc | 19,006 | — | |
| 30 Sept 2013 | CONVERSION | Evoke Pharma Inc | 19,006 | 0.00 USD | deriv |
| 01 Jul 2013 | CONVERSION | Esperion Therapeutics, Inc. | 30,462 | — | |
| 01 Jul 2013 | PURCHASE | Esperion Therapeutics, Inc. | 4,791 | 14.00 USD | first after silence |
| 01 Jul 2013 | CONVERSION | Esperion Therapeutics, Inc. | 30,462 | 0.00 USD | deriv |
| 01 Jul 2013 | OTHER | Esperion Therapeutics, Inc. | 1,193 | 0.00 USD | deriv |
| 01 Jul 2013 | OTHER | Esperion Therapeutics, Inc. | 8,346 | 0.00 USD | deriv |
| 31 Jan 2013 | SALE | CADENCE PHARMACEUTICALS INC | 314 | 4.71 USD |
1 purchase reported after at least 12 months of silence — most recent on 01 Jul 2013.